Technology
Novartis CEO: AI Could Cut Drug Development Time by Years
Bloomberg·November 20, 2026
Novartis CEO Vasant Narasimhan says artificial intelligence could help cut drug-development times from 12 years to eight and significantly improve the odds of bringing new medicines to market. Narasimhan, who also sits on Anthropic’s board, tells Bloomberg’s Francine Lacqua on "The Pulse" that AI is already helping Novartis speed up clinical trials, analyze data and identify new drug candidates. He also discusses the company’s growth outlook, drug pricing in Europe and the US, and AI regulation. (Source: Bloomberg)
Read the full story at Bloomberg →